This inventor holds 4 USPTO granted patents. Top assignee: The Procter Gamble Company. Active years: 2001-2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Surrey, GB (2001 - 2002)
- Walton on Thames, GB (2006)
Company Filing History:
Years Active: 2001-2006
Title: Innovations of Francis Joseph David Bealin-Kelly
Introduction
Francis Joseph David Bealin-Kelly is a notable inventor based in Walton on Thames, GB. He has made significant contributions to the field of pharmaceuticals, holding a total of 4 patents. His work focuses on developing innovative compositions that enhance the delivery and effectiveness of pharmaceutical agents.
Latest Patents
Among his latest patents is an invention for orally administered liquid compositions. This pharmaceutical composition demonstrates excellent physical stability while delivering concentrated levels of the active ingredients. Notably, these compositions do not require agitation or shaking prior to use, ensuring even and consistent dosing. Another significant patent is for throat soothing compositions, which consist of an edible shell and an aqueous filling containing a throat relief agent. This innovative design encapsulates the throat relief agents within vesicles, providing effective relief.
Career Highlights
Francis Bealin-Kelly is currently associated with The Procter & Gamble Company, where he continues to innovate in the pharmaceutical sector. His work has contributed to advancements in drug delivery systems, making medications more effective and user-friendly.
Collaborations
Throughout his career, Bealin-Kelly has collaborated with esteemed colleagues such as Bernhard Hanke and Paul Nienaber. These partnerships have fostered a creative environment that encourages the development of groundbreaking solutions in the pharmaceutical industry.
Conclusion
Francis Joseph David Bealin-Kelly's contributions to pharmaceutical innovations highlight his expertise and commitment to improving drug delivery systems. His patents reflect a dedication to enhancing patient care through effective and stable compositions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
